Developer docs
API playgroundTry for free, no card

Search company profiles

MatOrtho

Full company profile

uuid0002mqg

Namestring
MatOrtho
Legal namestring
MatOrtho Limited
Websiteurl
matortho.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

MatOrtho Limited is a privately held UK medical device company that designs, develops, manufactures, and commercialises orthopaedic implant devices focused on two surgical specialties: hip resurfacing arthroplasty and total knee replacement. The company is the originator of the medially stabilised (medial pivot) knee concept, launched in 1994 with the Medial Rotation Knee (MRK) and continued with the SAIPH Knee System from 2009, both of which substitute for the cruciate ligaments through a medial ball-and-socket articulation. In hip resurfacing, MatOrtho manufactures the ADEPT metal-on-metal system (clinically used since 2004) and the ReCerf all-ceramic monoblock resurfacing system, the latter being the world's first all-ceramic hip resurfacing device to receive CE Mark, FDA Breakthrough Device Designation, and the highest available ODEP 5A* rating. The company operates from Leatherhead, Surrey, with a wholly owned Australian subsidiary (MatOrtho Australia Pty Ltd) in Bella Vista, NSW, serving Australia and New Zealand.

MatOrtho generates revenue exclusively through B2B hardware sales of its implant devices to NHS hospitals, private hospitals, and orthopaedic specialty centres, supported by a dedicated direct field sales organisation in the UK and ANZ, with senior commercial leadership covering global sales. The company distributes through enterprise field sales, reference centres, surgeon peer-to-peer training programs, and educational events including the annual Resurfacing Redefined meeting, Product User Group Meetings, cadaveric instructional courses, and Dry Bone Workshops. Products are sold subject to country-specific regulatory approvals (CE Mark in Europe, FDA Breakthrough Designation in progress for the US, TGA and PLAC listing in Australia).

The customer base comprises consultant orthopaedic surgeons (key decision-makers), hospitals and healthcare institutions (procurement entities), and indirectly patients and GPs (referral sources). The company competes on the basis of clinical evidence accumulated over more than three decades from UK and Australian National Joint Registries, peer-reviewed survivorship data, intellectual property across multiple jurisdictions, and surgeon training infrastructure, targeting the global hip replacement market projected at approximately USD 15 billion by 2034.

Short descriptiontext

MatOrtho is a privately held UK medical device company that designs, manufactures, and sells orthopaedic implant devices — including the ADEPT and ReCerf hip resurfacing systems and the SAIPH and MRK medially stabilised knee systems — to hospitals and orthopaedic surgeons globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLeatherhead, United Kingdom
HQ citystring
Leatherhead
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopaedic implant devices, hip resurfacing systems, knee replacement implants, medical device manufacturing, joint replacement devices
Industry1 code
1Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryYes
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Orthopaedic Implant Devices
Social media profiles3 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Orthopaedic Implant Device Sales
TypeHardware Sales
Description

MatOrtho designs, develops, and manufactures orthopaedic implant devices including hip resurfacing systems (ReCerf, ADEPT) and knee replacement systems (SAIPH, MRK). Revenue is generated through the sale of these medical devices to hospitals, surgeons, and healthcare providers globally.

matortho.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1ADEPT
Description

Hip Resurfacing System - A trusted, first-class hip resurfacing solution clinically used since 2004

matortho.com
+3 more records
Core offering1 text field

MatOrtho designs, develops and manufactures orthopaedic implant devices focused on hip resurfacing and knee replacement systems. Its portfolio includes the ReCerf all-ceramic hip resurfacing device, the ADEPT metal-on-metal hip resurfacing system, and the SAIPH and MRK medially stabilised total knee replacement systems. The company sells these medical devices directly to hospitals and orthopaedic surgeons globally, supported by a network of reference centres for clinical training and surgeon education.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 95% patient satisfaction across hip and knee replacements
+5 more records
Product overview1 text field

MatOrtho® designs, develops and manufactures orthopaedic implant devices focused on hip resurfacing and knee replacement systems. The product portfolio includes: ADEPT® Hip Resurfacing System (metal-on-metal, ODEP 15A), ReCerf® Hip Resurfacing Arthroplasty (all-ceramic, ODEP 5A*), SAIPH® Knee System (medially-stabilised TKR, ODEP 10A), and MRK™ Medial Rotation Knee (earlier generation medial pivot knee, ODEP 15A). The company is known as 'The Home of Hip Resurfacing' and 'Originators of the medially stabilised knee'. Founded in 2010 by Mike Tuke, building on over 30 years of pioneering work from Finsbury Orthopaedics.

Product and service4 records
1ADEPT Hip Resurfacing System
CategoryOrthopaedic Implant Devices - Hip Resurfacing
Description

Metal-on-metal hip resurfacing system clinically used since 2004 with ODEP 15A rating for bearing sizes 48-58mm. Over 95% of Australian patients have not needed revision surgery at 10 years and 93.5% at 15 years. Designed for bone-preserving hip resurfacing arthroplasty for active patients.

2ReCerf Hip Resurfacing Arthroplasty
CategoryOrthopaedic Implant Devices - Hip Resurfacing
Description

World's first all-ceramic hip resurfacing device featuring ceramic monoblock acetabular cup and femoral head with no metal components. Offers better dimensional stability than metal counterparts and higher heat dissipation during cementing. Awarded 5A* ODEP rating, FDA Breakthrough Device Designation, CE Mark, TGA approval in Australia, and PLAC listing.

3SAIPH Knee System
CategoryOrthopaedic Implant Devices - Knee Replacement
Description

Medially stabilised total knee replacement system featuring a ball-and-socket articulation on the medial side designed to feel stable all the time while maintaining freedom of movement. Reaches 94.6% patient satisfaction with 96.5% reporting problems 'better than before surgery'. Awarded ODEP 10A rating and demonstrates zero revisions for aseptic tibial loosening in 900 procedures over 8.6 years in NJR.

4MRK Medial Rotation Knee
CategoryOrthopaedic Implant Devices - Knee Replacement
Description

Original medially stabilised knee implant launched in 1994, predecessor to the SAIPH Knee System. Features stem-and-pegs fixation interface with stippled cement interlocking design. Awarded ODEP 15A rating and has significantly lower revision rates for aseptic tibial loosening than all other total knee replacements in the National Joint Registry.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the world's largest orthopaedic device companies, offering hip and knee implants alongside many other medtech segments. Competes with MatOrtho in hip and knee reconstruction but with significantly broader portfolio and global sales reach.

TypeBroad incumbent
Description

Major orthopaedic implant manufacturer with leading positions in hip and knee reconstruction. Overlaps directly with MatOrtho's hip resurfacing and knee replacement portfolio but at much larger scale across primary and revision arthroplasty.

TypeBroad incumbent
Description

Orthopaedics and reconstructive implant business within J&J MedTech, offering hip and knee replacement systems globally. Direct competitor in joint reconstruction implants with significantly broader R&D and commercial infrastructure than MatOrtho.

TypeDirect peer
Description

US-based orthopaedic device company specialising in hip and knee replacement implants. Closely comparable business model focused on arthroplasty devices sold to orthopaedic surgeons and hospitals, similar in scale to MatOrtho.

TypeDirect peer
Description

German-based, family-owned orthopaedic implant specialist focused on hip and knee replacement systems. Highly comparable niche orthopaedic device company with a heritage similar to MatOrtho's Finsbury origins and an emphasis on specialised joint reconstruction implants.

TypeBroad incumbent
Description

Global medical device company with a large orthopaedics franchise including hip and knee replacement implants. Directly comparable to MatOrtho in hip and knee arthroplasty product categories, but operating at vastly greater scale with broader geographic coverage.

TypeDirect peer
Description

UK-based orthopaedic implant specialist with a heritage in hip resurfacing (historically connected to the McMinn/BHR lineage). Highly comparable niche focus on hip and knee implants, similar geographic heritage, and overlapping surgeon customer base in private and NHS hospitals.

TypeBroad incumbent
Description

Large medical technology group with an orthopaedic surgery division offering hip and knee endoprosthetics. Competes with MatOrtho in hip and knee arthroplasty but as part of a much broader medtech portfolio and global sales network.

TypeEmerging player
Description

Orthopaedic implant business focused on hip and knee reconstruction systems. Comparable product categories to MatOrtho with growing international presence, particularly in Asia and Europe, making it a relevant emerging competitor in joint replacement.

TypeBroad incumbent
Description

Medical device company with an orthopaedics and reconstructive franchise including hip and knee implants. Operates in the same joint reconstruction categories as MatOrtho but with a much broader product portfolio and global footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MatOrtho

Orthopaedic Implant Devicesmatortho.com

MatOrtho is a privately held UK medical device company that designs, manufactures, and sells orthopaedic implant devices — including the ADEPT and ReCerf hip resurfacing systems and the SAIPH and MRK medially stabilised knee systems — to hospitals and orthopaedic surgeons globally.

What MatOrtho does

MatOrtho Limited is a privately held UK medical device company that designs, develops, manufactures, and commercialises orthopaedic implant devices focused on two surgical specialties: hip resurfacing arthroplasty and total knee replacement. The company is the originator of the medially stabilised (medial pivot) knee concept, launched in 1994 with the Medial Rotation Knee (MRK) and continued with the SAIPH Knee System from 2009, both of which substitute for the cruciate ligaments through a medial ball-and-socket articulation. In hip resurfacing, MatOrtho manufactures the ADEPT metal-on-metal system (clinically used since 2004) and the ReCerf all-ceramic monoblock resurfacing system, the latter being the world's first all-ceramic hip resurfacing device to receive CE Mark, FDA Breakthrough Device Designation, and the highest available ODEP 5A* rating. The company operates from Leatherhead, Surrey, with a wholly owned Australian subsidiary (MatOrtho Australia Pty Ltd) in Bella Vista, NSW, serving Australia and New Zealand.

MatOrtho generates revenue exclusively through B2B hardware sales of its implant devices to NHS hospitals, private hospitals, and orthopaedic specialty centres, supported by a dedicated direct field sales organisation in the UK and ANZ, with senior commercial leadership covering global sales. The company distributes through enterprise field sales, reference centres, surgeon peer-to-peer training programs, and educational events including the annual Resurfacing Redefined meeting, Product User Group Meetings, cadaveric instructional courses, and Dry Bone Workshops. Products are sold subject to country-specific regulatory approvals (CE Mark in Europe, FDA Breakthrough Designation in progress for the US, TGA and PLAC listing in Australia).

The customer base comprises consultant orthopaedic surgeons (key decision-makers), hospitals and healthcare institutions (procurement entities), and indirectly patients and GPs (referral sources). The company competes on the basis of clinical evidence accumulated over more than three decades from UK and Australian National Joint Registries, peer-reviewed survivorship data, intellectual property across multiple jurisdictions, and surgeon training infrastructure, targeting the global hip replacement market projected at approximately USD 15 billion by 2034.

MatOrtho firmographics

Firmographics
Name
MatOrtho
Legal name
MatOrtho Limited
Website
https://matortho.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
51–100 employees
Short description
MatOrtho is a privately held UK medical device company that designs, manufactures, and sells orthopaedic implant devices — including the ADEPT and ReCerf hip resurfacing systems and the SAIPH and MRK medially stabilised knee systems — to hospitals and orthopaedic surgeons globally.
Ownership category
akta.pro rank

MatOrtho industry classification

Industry
Product category
Orthopaedic Implant Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

Keywords

  • Orthopaedic implant devices
  • Hip resurfacing systems
  • Knee replacement implants
  • Medical device manufacturing
  • Joint replacement devices

Where MatOrtho is headquartered

Location

Headquarters

HQ city
Leatherhead
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

MatOrtho business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Orthopaedic Implant Device Sales: MatOrtho designs, develops, and manufactures orthopaedic implant devices including hip resurfacing systems (ReCerf, ADEPT) and knee replacement systems (SAIPH, MRK). Revenue is generated through the sale of these medical devices to hospitals, surgeons, and healthcare providers globally.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

MatOrtho product offering

Product offering

Core offering

MatOrtho designs, develops and manufactures orthopaedic implant devices focused on hip resurfacing and knee replacement systems. Its portfolio includes the ReCerf all-ceramic hip resurfacing device, the ADEPT metal-on-metal hip resurfacing system, and the SAIPH and MRK medially stabilised total knee replacement systems. The company sells these medical devices directly to hospitals and orthopaedic surgeons globally, supported by a network of reference centres for clinical training and surgeon education.

Product overview

MatOrtho® designs, develops and manufactures orthopaedic implant devices focused on hip resurfacing and knee replacement systems. The product portfolio includes: ADEPT® Hip Resurfacing System (metal-on-metal, ODEP 15A), ReCerf® Hip Resurfacing Arthroplasty (all-ceramic, ODEP 5A*), SAIPH® Knee System (medially-stabilised TKR, ODEP 10A), and MRK™ Medial Rotation Knee (earlier generation medial pivot knee, ODEP 15A). The company is known as 'The Home of Hip Resurfacing' and 'Originators of the medially stabilised knee'. Founded in 2010 by Mike Tuke, building on over 30 years of pioneering work from Finsbury Orthopaedics.

Differentiator

Problem solved

Functional benefit

Brands

  • ADEPT: Hip Resurfacing System - A trusted, first-class hip resurfacing solution clinically used since 2004
  • SAIPH
  • ReCerf
  • Medial Rotation Knee (MRK)

Products and services

  • ADEPT Hip Resurfacing System Metal-on-metal hip resurfacing system clinically used since 2004 with ODEP 15A rating for bearing sizes 48-58mm. Over 95% of Australian patients have not needed revision surgery at 10 years and 93.5% at 15 years. Designed for bone-preserving hip resurfacing arthroplasty for active patients.
  • ReCerf Hip Resurfacing Arthroplasty World's first all-ceramic hip resurfacing device featuring ceramic monoblock acetabular cup and femoral head with no metal components. Offers better dimensional stability than metal counterparts and higher heat dissipation during cementing. Awarded 5A* ODEP rating, FDA Breakthrough Device Designation, CE Mark, TGA approval in Australia, and PLAC listing.
  • SAIPH Knee System Medially stabilised total knee replacement system featuring a ball-and-socket articulation on the medial side designed to feel stable all the time while maintaining freedom of movement. Reaches 94.6% patient satisfaction with 96.5% reporting problems 'better than before surgery'. Awarded ODEP 10A rating and demonstrates zero revisions for aseptic tibial loosening in 900 procedures over 8.6 years in NJR.
  • MRK Medial Rotation Knee Original medially stabilised knee implant launched in 1994, predecessor to the SAIPH Knee System. Features stem-and-pegs fixation interface with stippled cement interlocking design. Awarded ODEP 15A rating and has significantly lower revision rates for aseptic tibial loosening than all other total knee replacements in the National Joint Registry.

Quantifiable outcome

  • 95% patient satisfaction across hip and knee replacements
  • +5 more outcomes

Companies that use MatOrtho

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles1 record

MatOrtho technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

MatOrtho partnerships and signals

Strategic signal

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

MatOrtho competitors and assessment

Company assessment

Broad incumbents

  • Stryker: One of the world's largest orthopaedic device companies, offering hip and knee implants alongside many other medtech segments. Competes with MatOrtho in hip and knee reconstruction but with significantly broader portfolio and global sales reach.
  • Zimmer Biomet: Major orthopaedic implant manufacturer with leading positions in hip and knee reconstruction. Overlaps directly with MatOrtho's hip resurfacing and knee replacement portfolio but at much larger scale across primary and revision arthroplasty.
  • Johnson & Johnson (DePuy Synthes): Orthopaedics and reconstructive implant business within J&J MedTech, offering hip and knee replacement systems globally. Direct competitor in joint reconstruction implants with significantly broader R&D and commercial infrastructure than MatOrtho.
  • Smith & Nephew: Global medical device company with a large orthopaedics franchise including hip and knee replacement implants. Directly comparable to MatOrtho in hip and knee arthroplasty product categories, but operating at vastly greater scale with broader geographic coverage.
  • B. Braun: Large medical technology group with an orthopaedic surgery division offering hip and knee endoprosthetics. Competes with MatOrtho in hip and knee arthroplasty but as part of a much broader medtech portfolio and global sales network.
  • Enovis (formerly DJO): Medical device company with an orthopaedics and reconstructive franchise including hip and knee implants. Operates in the same joint reconstruction categories as MatOrtho but with a much broader product portfolio and global footprint.

Direct peers

  • Exactech: US-based orthopaedic device company specialising in hip and knee replacement implants. Closely comparable business model focused on arthroplasty devices sold to orthopaedic surgeons and hospitals, similar in scale to MatOrtho.
  • Waldemar Link: German-based, family-owned orthopaedic implant specialist focused on hip and knee replacement systems. Highly comparable niche orthopaedic device company with a heritage similar to MatOrtho's Finsbury origins and an emphasis on specialised joint reconstruction implants.
  • Corin Group: UK-based orthopaedic implant specialist with a heritage in hip resurfacing (historically connected to the McMinn/BHR lineage). Highly comparable niche focus on hip and knee implants, similar geographic heritage, and overlapping surgeon customer base in private and NHS hospitals.

Emerging players

  • MicroPort Orthopedics: Orthopaedic implant business focused on hip and knee reconstruction systems. Comparable product categories to MatOrtho with growing international presence, particularly in Asia and Europe, making it a relevant emerging competitor in joint replacement.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

MatOrtho social profiles

Digital presence

MatOrtho compliance and trust

Trust signal

Compliance7 records

MatOrtho financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MatOrtho leadership team

Management profile

Number of profiles

Profiles10 records

MatOrtho subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

MatOrtho funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MatOrtho M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MatOrtho

What does MatOrtho do?

MatOrtho designs, develops and manufactures orthopaedic implant devices focused on hip resurfacing and knee replacement systems. Its portfolio includes the ReCerf all-ceramic hip resurfacing device, the ADEPT metal-on-metal hip resurfacing system, and the SAIPH and MRK medially stabilised total knee replacement systems. The company sells these medical devices directly to hospitals and orthopaedic surgeons globally, supported by a network of reference centres for clinical training and surgeon education.

Is MatOrtho a public or private company?

MatOrtho is a private company. It is classified as private equity controlled and is currently operating.

When was MatOrtho founded?

MatOrtho was founded in 2010. It employs 51 to 100 people.

Where is MatOrtho based?

MatOrtho is headquartered in Leatherhead, United Kingdom, in the Europe region.

How does MatOrtho make money?

One revenue line is on record: orthopaedic Implant Device Sales.

Who are MatOrtho's main competitors?

Broad incumbents on record are Stryker, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), Smith & Nephew, B. Braun and Enovis (formerly DJO). Direct peers are Exactech, Waldemar Link and Corin Group. MicroPort Orthopedics is listed as an emerging player.

Does MatOrtho have an API?

No public API is recorded for MatOrtho.

What industry is MatOrtho in?

MatOrtho's product category is Orthopaedic Implant Devices. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireMatOrtho announces ReCerf® 5A* ODEP ratingMatOrtho, a UK-based orthopaedic device company, announced that its ReCerf Ceramic Hip Resurfacing system has been awarded a 5A* rating by the Orthopaedic Data Evaluation Panel (ODEP), the highest available rating at the five-year benchmark for orthopaedic implants. The rating reflects clinical data drawn from multiple international centres and worldwide markets. Dr Laura Richards, Clinical Research Manager at MatOrtho, said achieving this rating reflects both the quality of clinical evidence and the collaborative approach taken with experienced hip resurfacing surgeons internationally.PR NewswireMatOrtho kündigt ReCerf® 5A* ODEP-Bewertung anMatOrtho, a UK-based orthopaedic devices company, announced that its ReCerf® Ceramic Hip Resurfacing System received a 5A* rating from the Orthopaedic Data Evaluation Panel (ODEP), the highest available rating for the five-year benchmark category. The rating is supported by clinical data from multiple international centers and selected global markets, reflecting growing worldwide clinical experience with the system. This achievement represents an important milestone in the development of modern hip resurfacing and provides additional confidence in the evidence base supporting the device.PR NewswireMatOrtho announces ReCerf® 5A* ODEP ratingMatOrtho, a UK-based orthopaedic device company, announced that its ReCerf Ceramic Hip Resurfacing system has been awarded the highest available 5A* rating by the Orthopaedic Data Evaluation Panel (ODEP), an independent UK-based benchmarking system, at the five-year benchmark. The rating is supported by clinical data from multiple international centers, reflecting growing worldwide clinical experience with the system. The achievement marks an important milestone as interest in bone-conserving hip arthroplasty continues to re-emerge in selected markets.PR NewswireMatOrtho annonce le classement ReCerf® 5A* ODEPMatOrtho, a British orthopedic device company based in Leatherhead, announced that its ReCerf® ceramic hip resurfacing system received a 5A* rating from the UK-based Orthopaedic Data Evaluation Panel (ODEP), the highest available rating for five-year reference orthopedic implants. The rating is supported by clinical data from multiple international centers and global markets, reflecting the system's growing worldwide clinical experience and marking a significant milestone in modern hip resurfacing development.PR Newswire APACMatOrtho announces ReCerf® 5A* ODEP ratingMatOrtho announced that ReCerf has received a 5A* rating from the Orthopaedic Data Evaluation Panel, the highest five-year benchmark for orthopaedic implants. The rating is supported by clinical data from multiple international centres, reflecting growing worldwide experience with the ceramic hip resurfacing system.NewswireMatOrtho announces ReCerf® 5A* ODEP ratingMatOrtho announced that ReCerf received a 5A* rating from the Orthopaedic Data Evaluation Panel, the highest five-year benchmark for orthopaedic implants. The rating is supported by clinical data from multiple international centres, reflecting growing worldwide experience with the ceramic hip resurfacing system.openPR.comThe Global Hip Replacement Devices Market Size is growing at a CAGR of 5.51% by 2034, estimates DelveInsightDelveInsight published a market insights report estimating the global hip replacement devices market will grow from USD 9,254.50 million in 2025 to USD 14,917.71 million by 2034, reflecting a compound annual growth rate of 5.51%. Two product developments were highlighted in July 2025: MatOrtho Limited's ReCerf Hip Resurfacing Arthroplasty received CE mark certification, and Embody Orthopaedic's H1 hip implant, a spin-out from Imperial College London, also received CE mark approval for hip arthroplasty. North America is expected to remain the dominant regional market due to high incidence of hip fractures, escalating healthcare costs, and technological advancements by key players.PrivateequitywireConnection Capital clients invest GBP6.75m in MatOrthoPrivate investor clients of Connection Capital have invested GBP6.75 million in MatOrtho to support its international growth and product development. The funding will enable the UK-based orthopaedic device manufacturer to accelerate expansion into new markets and advance research on next-generation implant technology. MatOrtho has also appointed Simon Cartmell as a Non-Executive Director to support the management team.